(0.13%) 5 187.70 points
(0.08%) 38 884 points
(-0.10%) 16 333 points
(-0.40%) $78.07
(0.18%) $2.21
(-0.07%) $2 322.60
(0.13%) $27.58
(-0.18%) $986.60
(0.16%) $0.931
(0.42%) $10.94
(0.17%) $0.801
(0.00%) $91.45
Quarter results tomorrow
(bmo 2024-05-09)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others...
Stats | |
---|---|
आज की मात्रा | 1.14M |
औसत मात्रा | 4.36M |
बाजार मूल्य | 2 615.75B |
EPS | ¥0 ( 2024-02-14 ) |
अगली कमाई की तारीख | ( ¥17.89 ) 2024-05-09 |
Last Dividend | ¥16.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 71.14 |
ATR14 | ¥1.160 (0.05%) |
मात्रा सहसंबंध
Olympus Corporation सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Olympus Corporation सहसंबंध - मुद्रा/वस्त्र
Olympus Corporation वित्तीय
Annual | 2022 |
राजस्व: | ¥881.92B |
सकल लाभ: | ¥596.85B (67.68 %) |
EPS: | ¥113.22 |
FY | 2022 |
राजस्व: | ¥881.92B |
सकल लाभ: | ¥596.85B (67.68 %) |
EPS: | ¥113.22 |
FY | 2022 |
राजस्व: | ¥868.87B |
सकल लाभ: | ¥571.70B (65.80 %) |
EPS: | ¥90.22 |
FY | 2021 |
राजस्व: | ¥730.54B |
सकल लाभ: | ¥459.53B (62.90 %) |
EPS: | ¥10.05 |
Financial Reports:
No articles found.
Olympus Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥0 (N/A) |
¥16.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥1.625 | 2000-03-28 |
Last Dividend | ¥16.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 33 | -- |
Total Paid Out | ¥176.13 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.49 | -- |
Div. Sustainability Score | 8.42 | |
Div.Growth Potential Score | 2.63 | |
Div. Directional Score | 5.52 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8074.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7358.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
6594.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
5940.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
4620.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3857.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3099.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
1969.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
9533.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8439.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.295 | 1.500 | 4.10 | 6.14 | [0 - 0.5] |
returnOnAssetsTTM | 0.184 | 1.200 | 3.86 | 4.63 | [0 - 0.3] |
returnOnEquityTTM | 0.346 | 1.500 | 7.26 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.0742 | -1.000 | 9.26 | -9.26 | [0 - 1] |
currentRatioTTM | 2.07 | 0.800 | 4.63 | 3.70 | [1 - 3] |
quickRatioTTM | 1.510 | 0.800 | 5.82 | 4.66 | [0.8 - 2.5] |
cashRatioTTM | 0.917 | 1.500 | 6.01 | 9.02 | [0.2 - 2] |
debtRatioTTM | 0.208 | -1.500 | 6.54 | -9.81 | [0 - 0.6] |
interestCoverageTTM | 9.36 | 1.000 | 7.64 | 7.64 | [3 - 30] |
operatingCashFlowPerShareTTM | 25.69 | 2.00 | 1.435 | 2.87 | [0 - 30] |
freeCashFlowPerShareTTM | -30.63 | 2.00 | -10.00 | -10.00 | [0 - 20] |
debtEquityRatioTTM | 0.406 | -1.500 | 8.37 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.671 | 1.000 | 2.15 | 2.15 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.101 | 1.000 | 9.98 | 9.98 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.101 | 1.000 | -0.552 | -0.552 | [0.2 - 2] |
assetTurnoverTTM | 0.624 | 0.800 | 9.17 | 7.34 | [0.5 - 2] |
Total Score | 8.42 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.35 | 1.000 | 9.06 | 0 | [1 - 100] |
returnOnEquityTTM | 0.346 | 2.50 | 8.24 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -30.63 | 2.00 | -10.00 | -10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.768 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 25.69 | 2.00 | 1.435 | 2.87 | [0 - 30] |
payoutRatioTTM | 0.0742 | 1.500 | 9.26 | -9.26 | [0 - 1] |
pegRatioTTM | 0.102 | 1.500 | -2.65 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0335 | 1.000 | -1.663 | 0 | [0.1 - 0.5] |
Total Score | 2.63 |
Olympus Corporation
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं